Single and Multiple Ascending Dose Study of KN-002

计划入组 117 人 · 首次发布于 2021 年 8 月 16 日

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

计划入组 534 人

KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer

计划入组 98 人 · 首次发布于 2023 年 8 月 14 日

EV-302

EV-102

KN-032

H e y l Chemisch-pharmazeutische Fabrik GmbH & Co. KG

Germany

Robert Wood Johnson Medical School

United States

Asceneuron SA

Switzerland

Adverse Events Linked to Better Survival Outcomes in Enfortumab Vedotin Treatment for Urothelial Cancer

NHS Approves Breakthrough Bladder Cancer Treatment That Doubles Survival Rates

Enfortumab Vedotin Plus Pembrolizumab Shows Durable Response in Advanced Urothelial Carcinoma